Table 1.
Demographic, clinical, laboratory and histopathological data of six patients with HCC and SLF submitted to liver transplantation in Recife – Brazil.
|
Patients |
||||||
|---|---|---|---|---|---|---|
| 1 | 2 | 3 | 4 | 5 | 6 | |
| Sex | Male | Male | Male | Female | Male | Male |
| Age (years) | 53 | 45 | 46 | 34 | 70 | 57 |
| UGB | Yes | No | No | Yes | Yes | No |
| Splenectomy | No | No | No | Yes | Yes | No |
| LFS | Ascites | No | No | Ascites | Ascites + jaundice | No |
| MELD | 12 | 7 | 7 | 10 | 15 | 8 |
| Comorbidities | None | DM, AC | None | None | DM, AC | DM |
| Liver/body weight (%) | 1.61 | 4.50 | 2.22 | 2.14 | 1.34 | 1.60 |
| Liver parenchyma | SLF + SG | SLF + SG | SLF | SLF + SG | SLF | SLF + SG |
| Milan criteria | In | Out | Out | In | In | Out |
HCC, hepatocellular carcinoma; SLF, schistosomal liver fibrosis; UGB, upper gastrointestinal bleeding; LFS, liver failure signs; MELD, model for end-stage liver disease; DM, diabetes mellitus; AC, alcohol consumption; SG, schistosomal granuloma.